Please use this identifier to cite or link to this item:
Title: FATE: the new partnership to Fight Against TB in Central and Eastern Europe
Authors: Jagielski, Tomasz
Aleksa, Alena
Bachiyska, Elizabeta
Bakos, Ágnes
Crudu, Valeriu
Dziadek, Jaroslaw
Homolka, Jirí
Homorodean, Daniela
Jansone, Inta
Katalinic-Jankovic, Vera
Krenke, Rafal
Kuzmic, Uroš
Nikolayevskyy, Vlad
Nikolenka, Alena
Osmani, Gjyle Mulliqi
Papaventsis, Dimitrios
Pole, Ilva
Porvazník, Igor
Savic, Branislava
Shubladze, Natalia
Solovic, Ivan
Szabó, Nóra
Tafaj, Silva
Ustamujic, Aida
van Ingen, Jakko
Vasiliauskiene, Edita
Yablonsky, Peter K.
Zemanova, Ilona
Zhuravlev, Viacheslav
Žolnir-Dovc, Manca
Mokrousov, Igor V. 
Issue Date: Apr-2017
Publisher: Elsevier
Journal: Lancet Infectious Diseases 
Abstract: Central and eastern Europe is a hotspot for drug-resistant tuberculosis and most countries in the region face similar threats (figure, appendix) and opportunities, including the introduction of molecular tests for rapid diagnosis of drug-resistant tuberculosis. Yet, regional collaboration and a single recognisable organisation that could act as an interface with other relevant parties, such as the WHO, European Centre for Disease Prevention and Control, non-governmental organisations (NGOs), funding agencies, and scientific consortia, are still lacking. To improve this situation, most relevant tuberculosis authorities in the region, including the national reference laboratories, have set up the Partnership to Fight Against TB in Central and Eastern Europe (FATE).
ISSN: 14733099
DOI: 10.1016/S1473-3099(17)30120-2
Appears in Collections:Journal articles

Show full item record


checked on Apr 17, 2019

Page view(s)

checked on Apr 20, 2019

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.